Maze Therapeutics
(NASDAQ) MAZE
Maze Therapeutics Financials at a Glance
Market Cap
$1.65B
Revenue (TTM)
$20.00M
Net Income (TTM)
-$122.54M
EPS (TTM)
-$2.54
P/E Ratio
-11.72
Dividend
$0.00
Beta (Volatility)
0.95 (Low)
Dividend
$0.00
Beta (Volatility)
0.95 (Low)
Price
$29.83
Volume
43,999
Open
$29.53
Price
$29.83
Volume
43,999
Open
$29.53
Previous Close
$29.83
Daily Range
$29.24 - $30.49
52-Week Range
$10.98 - $53.65
Estimated Earnings Date
Aug 11, 2026
Dividend
$0.00
Beta (Volatility)
0.95 (Low)
Price
$29.83
Volume
43,999
Open
$29.53
Previous Close
$29.83
Daily Range
$29.24 - $30.49
52-Week Range
$10.98 - $53.65
Estimated Earnings Date
Aug 11, 2026
MAZE News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Maze Therapeutics
Industry
Pharmaceuticals
Sector
Health CareEmployees
141
CEO
Jason V. Coloma, PhD, MBA
Website
www.mazetx.comHeadquarters
South San Francisco, CA 94080, US
MAZE Financials
Key Financial Metrics (TTM)
Gross Margin
92.04%
Operating Margin
-670.25%
Net Income Margin
-612.71%
Return on Equity
-36.63%
Return on Capital
-37.78%
Return on Assets
-29.20%
Earnings Yield
-8.53%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.65B
Shares Outstanding
55.35M
Volume
44.00K
Avg. Volume
729.49K
Financials (TTM)
Gross Profit
$18.41M
Operating Income
-$134.05M
EBITDA
-$119.51M
Operating Cash Flow
-$121.54M
Capital Expenditure
-$588.00K
Free Cash Flow
-$122.13M
Cash & ST Invst.
$352.38M
Total Debt
$61.22M
Maze Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$20.00M
N/A
Gross Profit
$19.56M
N/A
Gross Margin
97.78%
N/A
Market Cap
$1.65B
N/A
Market Cap/Employee
$11.70M
N/A
Employees
141
N/A
Net Income
-$24.21M
+26.2%
EBITDA
-$22.90M
+28.7%
Quarterly Fundamentals
Total Cash
$352.38M
+19.7%
Total Debt
$61.22M
+137.1%
Accounts Receivable
$20.00M
N/A
Inventory
$0.00
N/A
Long Term Debt
$56.39M
+166.6%
Short Term Debt
$4.84M
+3.5%
Return on Assets
-29.20%
N/A
Return on Invested Capital
-33.64%
N/A
Free Cash Flow
-$39.21M
-31.5%
Operating Cash Flow
-$39.11M
-32.5%